Stocks and InvestingStocks and Investing
Fri, September 22, 2023
Thu, September 21, 2023
Wed, September 20, 2023
Tue, September 19, 2023

Robert Burns Reiterated (ADCT) at Strong Buy and Held Target at $12 on, Sep 19th, 2023


Published on 2024-10-28 06:28:33 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "ADC Therapeutics SA" (ADCT) at Strong Buy and Held Target at $12 on, Sep 19th, 2023.

Robert has made no other calls on ADCT in the last 4 months.



There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Cheng of "JP Morgan" Upgraded from Sell to Hold on, Thursday, August 10th, 2023
  • Jeffrey Hung of "Morgan Stanley" Reiterated at Hold and Held Target at $5 on, Tuesday, July 11th, 2023


This is the rating of the analyst that currently disagrees with Robert


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Tuesday, September 12th, 2023